LCMS webinars focusing on LC/HRMS - page 24

In the seventh episode you will hear about fundamentals of MS in LC/MS, LC/MS/MS & TOF Systems.

Discover how to harness the power of quantitative analysis for effective screening and identification of potential suspect compounds.

This presentation highlights the importance of studying proteins in understanding drug mechanisms of action and identifying potential targets for cancer treatment.

Learn the spatial biology utility of MALDI Imaging. Understand multiomics workflows and the applications to disease-based research.

A HTS proteomics approach that utilizes label-free, single-shot dia-PASEF® mass spectrometry to identify novel degrader targets on a large scale with unmatched coverage, accuracy, and speed.

We will explore the critical aspects of differentiating good from bad data and how this distinction can significantly influence your results.

Hear about the latest advancements in translational proteomics and metabolomics.

Hear about the latest advancements in translational proteomics and metabolomics.

Tissue sample processing, data acquisition with a Bruker timsTOF Ultra, and data analysis will be reviewed as tools for the development and validation of HLA peptide targets for immunopeptidomic development.

Alithea has a significant track record in the absolute quantification of HLA peptides, off-target toxicity predictions and target discovery.